FDA chief Tukaram flags huge price gaps in medical devices, seeks Centre’s intervention
Cite this
Citations are auto-generated; verify before publishing. The news classification is PolicyDhara's, not the source's.
News coverage — journalism about policy, not a policy document. Useful as timely context; the underlying instrument is linked where known.
Summary
The report cited that an IV set purchased for ₹11.05 had a declared MRP of ₹325, while an infusion set purchased for ₹11 had an MRP of ₹201.